(Q40510919)
Statements
1 reference
Single-dose pharmacokinetics and tolerability of alendronate 35- and 70-milligram tablets in children and adolescents with osteogenesis imperfecta type I. (English)
1 reference
1 reference
Ward LM
1 reference
Denker AE
1 reference
Porras A
1 reference
Shugarts S
1 reference
Kline W
1 reference
Travers R
1 reference
Mao C
1 reference
Maes A
1 reference
Larson P
1 reference
Deutsch P
1 reference
Glorieux FH
1 reference
12 April 2005
1 reference
1 reference
90
1 reference
7
1 reference
4051-4056
1 reference
Identifiers
1 reference
1 reference